Brian Abbott, MD, MBA

Brian Abbott, MD, MBA

  • Staff Physician, Hospitalist Medicine Program

Education

MD — University of Tennessee, Memphis (1997)
MBA — University of Colorado, Denver (2016)
Pediatric Residency — St. Louis Children's Hospital
Pediatric Hematology-Oncology Fellowship — St. Jude Children's Research Hospital
Stem Cell Transplant Fellowship — University of Colorado

Awards and Professional Activities

  • 1994 American Brain Tumor Association, Medical Student Research Award
  • 1997 Alpha Omega Alpha, Distinguished Graduate Award
  • 1997 University of Tennessee: Medical Student Cancer Research Award
  • 2000 Laboratory Training for Clinical Oncologists (NIH Grant)
  • 2004-present The Bone Marrow Foundation, Medical Advisory Board
  • 2014-present Medical Director, Camp Make-A-Dream (Missoula, Montana)

Research Interests

  • Inherited cancer syndromes

Selected Publications

Saam J, Abbott B, Wenstrup R. Overlap Between Lynch Syndrome and Hereditary Breast and Ovarian Cancer Syndrome among Personal and Family Cancer Histories in Patients Tested for Hereditary Cancer Syndromes. Society of Gynecologic Oncology, 2014.

Saam J, et al, Abbott BL. Prevalence of DPYD gene mutations among patients receiving 5-FU therapy. American Society of Clinical Oncology - Gastrointestinal, 2012.

Abbott BL. Dasatinib: From Treatment of Imatinib-Resistant or -Intolerant Patients With Chronic Myeloid Leukemia (CML) to Treatment of Patients With Newly Diagnosed Chronic Phase CML. Clinical Therapeutics, 2012. 

Li Y, Clough N, Hogan CJ, Abbott BL, Dai Z. BCR-ABL induces abnormal cytoskeleton remodeling, B1 integrin clustering, and increased cell adhesion to fibronectin through ABL interactor 1 pathway. J Cell Sci, 120:1436-46, 2007.      

Abbott BL. American College Physicians, Physicians Information and Education Resource (PIER)  Section editor: "Chronic Lymphocytic Leukemia," http://www.ACPOnline.org, 2005-2007.

Abbott BL. Lymphoma and Myeloma: a 2006 American Society of Clinical Oncology meeting update. Clinical Lymphoma and Myeloma 7(1):30-2, 2006.

Abbott BL. Chronic Lymphocytic Leukemia: Recent Advances in Diagnosis and Treatment. CME Activity, The Oncologist, January 2006.

Chen R, Abbott BL, Myint H. Treatment of HIV associated Burkitt’s lymphoma in the presence of severe hepatic dysfunction: a case report and literature review. Clinical Advances in Hematology & Oncology 4:844-7, 2006.  

Abbott BL, Patton M. 140 Things you need to know about your autologous bone marrow or stem cell transplant. MGC Publications, 2005. ISBN 0976806002.

Pacheco TR, Abbott BL. Leukemic and lymphomatous infiltrates of the skin. Dermatology Secrets, 3rd edition, 2005.

Abbott BL. Inside Blood: Does "Mini-transplantation" have "mini toxicity?"  Blood, September 1, 2004. (Invited editorial)

Willams CB, Abbott BL, et al.  Dose modification protocol using intravenous busulfan and cyclophosphamide followed by autologous or allogeneic peripheral blood stem cell transplantation in patients with hematologic malignancies. Biology of Blood and Marrow Transplantation, 2004.

Abbott BL, Rubnitz JE, Tong X, Srivastava DK, Pui CH, Ribeiro RC, Razzouk BI. Clinical Significance of CNS Involvement at Diagnosis of Pediatric Acute Myeloid Leukemia. Leukemia 18(1):187, 2004. 

Abbott BL, Colapietro AM, Barnes Y, Marini F, Andreeff M, Sorrentino BP. Low Levels of ABCG2 Expression in Adult AML Blast Samples. Blood 100(13):4594-601, 2002.

Abbott BL, Brenner MK. Sodium Butyrate Improves Neuroblastoma Tumor Vaccine Efficacy. American Association of Cancer Research (AACR) Annual Meeting, 1998.

Last update: April 2017